We fund research designed to find innovative ways to develop new drugs, barriers to the insects and worms that carry the parasites, diagnostics and other tools against infectious diseases in developing countries. We also look for new ways to distribute and increase access to these tools. Work led by researchers from disease endemic countries is always one of our top considerations.
Calls for grant applications or/and letters of interest
Joint TDR/WPR Small Grants Scheme for Implementation Research
Deadline for submission: 30 June 2015
Only applicants from the low- and middle-income countries of the WHO Western Pacific Region eligible (please refer to the list below)
The World Health Organization Western Pacific Region (WPR) and the Special Programme for Research and Training in Tropical Diseases (TDR) are pleased to announce the 2015-2016 call for applications for the Joint TDR/WPR Small Grants Scheme for implementation research in infectious diseases of poverty.
Investigation of the magnitude and causes of residual malaria parasite transmission in selected settings
Deadline for submission: 16 June 2015, 17:00 CET
Research institutions working on malaria transmission in the WHO regions of Africa, the Americas, the South-East Asia and the Western Pacific are invited to submit collaborative research proposals to investigate the magnitude and causes of residual malaria parasite transmission in low- to high-transmission areas.
Research proposal objectives must include the production of updated data on residual malaria from selected settings in Africa, Americas, Asia and/or Western Pacific on the prevalence of residual malaria and scientific evidence on the causes of this residual malaria through investigations of entomological, social and environmental determinants.
Joint call for proposals with EDCTP and the UK Medical Research Council:
Research and capacity development in support of the EVD response
Deadline for submission: 6 August 2015, 17:00 CET (extended)
The purpose of this Call for Proposals is to build and strengthen regional, national, institutional and individual capacities to conduct high quality health research (e.g. clinical trials, operational and/or implementation research) during infectious disease outbreaks resulting in health emergencies.